多参数流式细胞术辅助诊断原发性浆细胞白血病
本研究在591例新诊断多发性骨髓瘤患者中,比较外周血涂片形态学与多参数流式细胞术(MFC)对循环浆细胞(cPCs)的定量评估。MFC检测到≥200 cPCs/μL可识别涂片≥5% cPCs的患者(特异性99%,敏感性77%),且该阈值患者的中位至下次治疗时间和总生存期均显著缩短。MFC可辅助涂片形态学提高原发性浆细胞白血病(pPCL)的识别。
要点
- MFC检测外周血cPCs≥200/μL可高特异性识别涂片≥5% cPCs的pPCL患者。
- MFC阈值≥200 cPCs/μL者中位TTNT为18个月,中位OS为38个月。
- MFC可与外周血涂片联合用于新诊断多发性骨髓瘤中pPCL的识别。
核心结论
- MFC定量外周血cPCs可辅助涂片形态学提高新诊断多发性骨髓瘤患者中pPCL的识别。
研究设计与样本
- 回顾性评估591例新诊断多发性骨髓瘤患者,治疗前同时行外周血涂片形态学和MFC免疫表型评估。
主要发现
- MFC检测≥200 cPCs/μL(25例,占5%)识别涂片≥5% cPCs的敏感性77%、特异性99%。
- MFC≥200 cPCs/μL者中位TTNT为18个月,其余患者为30个月。
- MFC≥200 cPCs/μL者中位OS为38个月,其余患者为70个月。
关键数值与推荐
- MFC检测cPCs≥200/μL作为识别涂片≥5% cPCs的定量阈值,特异性99%、敏感性77%。
临床怎么用
- 对初诊多发性骨髓瘤患者,可联合外周血涂片和MFC定量cPCs以提高pPCL诊断准确性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The diagnosis of primary plasma cell leukemia (pPCL) has been made by quantifying circulating plasma cells (cPCs) morphologically on a peripheral blood (PB) smear. However, this technique is not sufficiently sensitive. Multiparametric flow cytometry (MFC) provides a readily available and highly sensitive method to identify and quantify cPCs that could complement PB smear assessment. However, an optimal quantitative cutoff for cPCs by MFC to identify pPCL has not been established. Thus, a total of 591 patients newly diagnosed multiple myeloma (NDMM) patients who had their PB samples evaluated morphologically by PB smear, and immunophenotypically by MFC prior to beginning therapy were evaluated. The presence of ≥200 cPCs/μL by MFC (N = 25 or 5% of the total population) was chosen to identify patients with ≥5% cPCs by PB smear with a specificity of 99% and a sensitivity of 77%. For patients with ≥200 cPCs/μL by MFC compared to the remainder of the cohort, the median Time to next therapy (TTNT) was 18 vs 30 months and the median OS was 38 vs 70 months respectively. Thus, MFC assessment of PB can be utilized in conjunction with the morphological assessment of a PB smear to aid in improving the identification of pPCL among NDMM patients.
引用
- Evans LA, Jevremovic D, Nandakumar B, et al. Utilizing multiparametric flow cytometry in the diagnosis of patients with primary plasma cell leukemia. Am J Hematol. 2020. PMID: 32129510. doi:10.1002/ajh.25773
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。